•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
Maravai (MRVI) Advances in RNA Research With New Collaboration
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Seizing Growth Opportunities
Q1 2024 Maravai LifeSciences Holdings Inc Earnings Call Transcript
Maravai LifeSciences Holdings GAAP EPS of -$0.09 misses by $0.04, revenue of $64.2M beats by $3.65M
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Wall Street Analysts Are Bullish on Top Healthcare Picks
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Should You Sell Maravai LifeSciences (MRVI)?
•
in mil. unless spec.Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.